Rong Hu, PhD
Associate Research Scientist in Pharmacology
Research & Publications
Biography
Coauthors
Selected Publications
- Abstract 2252: YIV-906 (PHY906) enhanced the anti-tumor activity of immune checkpoint blockade therapy (Anti-PD1) against liver cancer by changing the tumor micro-environment associated with M1 macrophages infiltrationLam W, Yang X, Jiang Z, han X, Guan F, Hu R, Xu C, Cai W, Cheng W, Liu S, Cai Y, Rattray N, Johnson C, Chen L, Cheng Y. Abstract 2252: YIV-906 (PHY906) enhanced the anti-tumor activity of immune checkpoint blockade therapy (Anti-PD1) against liver cancer by changing the tumor micro-environment associated with M1 macrophages infiltration. 2019, 2252-2252. DOI: 10.1158/1538-7445.sabcs18-2252.
- Abstract 2252: YIV-906 (PHY906) enhanced the anti-tumor activity of immune checkpoint blockade therapy (Anti-PD1) against liver cancer by changing the tumor micro-environment associated with M1 macrophages infiltrationLam W, Yang X, Jiang Z, han X, Guan F, Hu R, Xu C, Cai W, Cheng W, Liu S, Cai Y, Rattray N, Johnson C, Chen L, Cheng Y. Abstract 2252: YIV-906 (PHY906) enhanced the anti-tumor activity of immune checkpoint blockade therapy (Anti-PD1) against liver cancer by changing the tumor micro-environment associated with M1 macrophages infiltration. Cancer Research 2019, 79: 2252-2252. DOI: 10.1158/1538-7445.am2019-2252.
- The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)Lam W, Jiang Z, Guan F, Hu R, Liu SH, Chu E, Cheng YC. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018). BMC Complementary Medicine And Therapies 2014, 14: 490. PMID: 25510341, PMCID: PMC4302098, DOI: 10.1186/1472-6882-14-490.
- Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Thymidine Analog▿Paintsil E, Dutschman GE, Hu R, Grill SP, Lam W, Baba M, Tanaka H, Cheng YC. Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Thymidine Analog▿. Antimicrobial Agents And Chemotherapy 2007, 51: 3870-3879. PMID: 17724147, PMCID: PMC2151449, DOI: 10.1128/aac.00692-07.
- Comparison of the Phosphorylation of 4′-Ethynyl 2′,3′-Dihydro-3′-Deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs▿Hsu CH, Hu R, Dutschman GE, Yang G, Krishnan P, Tanaka H, Baba M, Cheng YC. Comparison of the Phosphorylation of 4′-Ethynyl 2′,3′-Dihydro-3′-Deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs▿. Antimicrobial Agents And Chemotherapy 2007, 51: 1687-1693. PMID: 17353236, PMCID: PMC1855562, DOI: 10.1128/aac.01432-06.